LATTICE MEDICAL
Lattice Medical develops MATTISSE, a fully degradable 3D printed breast implant for natural, uncomplicated breast restoration.
- B2B
- B2C
- manufacturing
- selling own inventory
- health
- medical devices
- biotechnology
- hardware
- 3d technology
- deep tech
- biotechnology
- horizon europe
- sustainable development goals
- dt and ls
- radar de l'innovation
- tech for business
- oncology
- eit ecosystem
- observatoire industrial tech
- observatoire deeptech
- surgery
- eit health
- tech for patients
- digital care
- biotech, medtech and e-health
- femtech
- eicfund
- observatoire healthtech
- biomaterials
- medical implants
- tissue engineering
- regenerative medicine
- french tech 2030
- bridgehead global 2020 (eit health)
- bridgehead global (eit health)
| EUR | 2019 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Developer of a medical device designed to help manufacture and designing of soft tissue reconstruction devices for breast reconstruction. The company specializes in implants for breast reconstruction after cancer that help in personalized reconstruction with a single surgery, enabling health professionals to get access to a medical device that assists in reconstructing the lost volume of the patients after mastectomy.
Keywords: Healthcare Devices, Services, Supplies, Autologous Fat Tissue, Soft Tissue Implant, Soft Tissue Repair, Soft Tissue Replacement, Soft Tissue Therapeutics, Soft Tissue Treatment.